Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred Schwab

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Japanese Journal of Clinical Oncology|April 27, 2013
Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomasKiyoshi Asada, Naoko Watanabe, Yohko Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.
Cancer Letters|August 30, 2008
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cellsChristian Praml, Wolfgang Schulz, Andreas Claas, et al.
Cancer Letters|August 10, 2007
Suppression of polyploidy by the BRCA2 proteinEvgeny Sagulenko, Larissa Savelyeva, Volker Ehemann, et al.
International Journal of Cancer|December 13, 2007
Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cellsHedwig E Deubzer, Volker Ehemann, Frank Westermann, et al.
Cancer Letters|June 6, 2009
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastomaIsabella Eckerle, Daniel Muth, Julia Batzler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Characterization and development of a peptide (p160) with affinity for neuroblastoma cellsVasileios Askoxylakis, Walter Mier, Sabine Zitzmann, et al.
Genes, Chromosomes & Cancer|June 29, 2006
Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastomaQing-Rong Chen, Sven Bilke, Jun S Wei, et al.
Cancer Letters|February 12, 2008
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitroHedwig E Deubzer, Volker Ehemann, Andreas E Kulozik, et al.
Cancer Letters|November 28, 2006
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified diseaseAndré Oberthuer, Patrick Warnat, Yvonne Kahlert, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Japanese Journal of Clinical Oncology|April 27, 2013
Stronger prognostic power of the CpG island methylator phenotype than methylation of individual genes in neuroblastomasKiyoshi Asada, Naoko Watanabe, Yohko Nakamura, et al.
European Journal of Cancer (Oxford, England : 1990)|January 16, 2007
Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region at 1p36 in neuroblastomaKai-Oliver Henrich, Andreas Claas, Christian Praml, et al.
Cancer Letters|August 30, 2008
Genetic variation of Aflatoxin B1 aldehyde reductase genes (AFAR) in human tumour cellsChristian Praml, Wolfgang Schulz, Andreas Claas, et al.
Cancer Letters|August 10, 2007
Suppression of polyploidy by the BRCA2 proteinEvgeny Sagulenko, Larissa Savelyeva, Volker Ehemann, et al.
International Journal of Cancer|December 13, 2007
Histone deacetylase inhibitor Helminthosporium carbonum (HC)-toxin suppresses the malignant phenotype of neuroblastoma cellsHedwig E Deubzer, Volker Ehemann, Frank Westermann, et al.
Cancer Letters|June 6, 2009
Regulation of BIRC5 and its isoform BIRC5-2B in neuroblastomaIsabella Eckerle, Daniel Muth, Julia Batzler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 3, 2006
Characterization and development of a peptide (p160) with affinity for neuroblastoma cellsVasileios Askoxylakis, Walter Mier, Sabine Zitzmann, et al.
Genes, Chromosomes & Cancer|June 29, 2006
Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastomaQing-Rong Chen, Sven Bilke, Jun S Wei, et al.
Cancer Letters|February 12, 2008
Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitroHedwig E Deubzer, Volker Ehemann, Andreas E Kulozik, et al.
Cancer Letters|November 28, 2006
Classification of neuroblastoma patients by published gene-expression markers reveals a low sensitivity for unfavorable courses of MYCN non-amplified diseaseAndré Oberthuer, Patrick Warnat, Yvonne Kahlert, et al.
Pageof 7